| 000 | 01580 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511211121.0 | ||
| 264 | 0 | _c19910918 | |
| 008 | 199109s 0 0 eng d | ||
| 022 | _a0041-008X | ||
| 024 | 7 |
_a10.1016/0041-008x(91)90296-q _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSikorski, E E | |
| 245 | 0 | 0 |
_aSplenic cell targets in gallium arsenide-induced suppression of the primary antibody response. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cAug 1991 |
||
| 300 |
_a129-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibody Formation _xdrug effects |
| 650 | 0 | 4 |
_aArsenic _xadministration & dosage |
| 650 | 0 | 4 | _aArsenicals |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 |
_aGallium _xadministration & dosage |
| 650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
| 650 | 0 | 4 |
_aImmunoglobulin M _xbiosynthesis |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitogens _xpharmacology |
| 650 | 0 | 4 |
_aSpleen _xcytology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aTrachea |
| 700 | 1 | _aBurns, L A | |
| 700 | 1 | _aStern, M L | |
| 700 | 1 | _aLuster, M I | |
| 700 | 1 | _aMunson, A E | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 110 _gno. 1 _gp. 129-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0041-008x(91)90296-q _zAvailable from publisher's website |
| 999 |
_c1877972 _d1877972 |
||